Statistics and Its Interface · 2010 · 36 citations · 37 references
Public HealthBiostatisticsBayesian BiostatisticsFrailtySurvival AnalysisBayesian Latent Variable ModelsBayesian Survival AnalysisFrailty ModelsLongitudinal Data AnalysisSurvival ModelingTime-dependent CovariatesBayesian Joint Longitudinal-survival ModelsCensoring DistributionCholesky DecompositionHigh-dimensional Heterogeneous EffectsLinear Mixed ModelsRandom Effects Survival ModelsVariance-covariance Matrix EstimationVariance-covariance Structure
This article proposes a joint model for longitudinal measurements and competing risks survival data. The model consists of a linear mixed effects sub-model with t-distributed measurement errors for the longitudinal outcome, a proportional cause-specific hazards frailty sub-model for the survival outcome, and a regression sub-model for the variance-covariance matrix of the multivariate latent random effects based on a modified Cholesky decomposition. A Bayesian MCMC procedure is developed for parameter estimation and inference. Our method is insensitive to outlying longitudinal measurements in the presence of non-ignorable missing data due to dropout. Moreover, by modeling the variance-covariance matrix of the latent random effects, our model provides a useful framework for handling high-dimensional heterogeneous random effects and testing the homogeneous random effects assumption which is otherwise untestable in commonly used joint models. Finally, our model enables analysis of a survival outcome with intermittently measured time-dependent covariates and possibly correlated competing risks and dependent censoring, as well as joint analysis of the longitudinal and survival outcomes. Illustrations are given using a real data set from a lung study and simulation.
37
Monte Carlo sampling methods using Markov chains and their applications
W. Keith Hastings · Biometrika · 1970 · 15.2K citations
Robust Regression: Asymptotics, Conjectures and Monte Carlo
Peter J. Huber · The Annals of Statistics · 1973 · 2.4K citations · Full text
Cyclophosphamide versus Placebo in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text